Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. - Wikidata - awgldk - TriplyDB

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.

http://www.wikidata.org/entity/Q35905639

about

Standards of medical care in diabetes--2012 A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline Endocrine Risk Factors for Cognitive Impairment Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease Does Intensive Glucose Control Prevent Cognitive Decline in Diabetes? A Meta-Analysis Type 2 diabetes and cognitive impairment: linking mechanisms Diabetes mellitus and cognitive impairments Standards of medical care in diabetes--2013 Diabetes in older adults Caloric restriction improves diabetes-induced cognitive deficits by attenuating neurogranin-associated calcium signaling in high-fat diet-fed mice Effect of diabetes on brain structure: the action to control cardiovascular risk in diabetes MR imaging baseline data Impact of diabetes on cognitive function and brain structure.Diabetes and Cognitive Impairment.Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of Atherosclerosis.Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes Cognitive and physical function in chronic kidney disease.Diabetes and the brain: issues and unmet needs.Type 2 diabetes as a risk factor for cognitive impairment: current insights.Outcome markers for clinical trials in cerebral amyloid angiopathy.Duration of type 2 diabetes and very low density lipoprotein levels are associated with cognitive dysfunction in metabolic syndrome.Diabetes. Can tight glycemic control in diabetes benefit cognition?The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes The synergistic effects of HIV, diabetes, and aging on cognition: implications for practice and research Functional MRI signal fluctuations: a preclinical biomarker for cognitive impairment in type 2 diabetes?Diabetes in older adults: a consensus report Diabetes and cognitive outcomes in a nationally representative sample: the National Health and Aging Trends Study Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment.Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.White matter hyperintensities and imaging patterns of brain ageing in the general population.Effect of hypoglycemia on brain structure in people with type 2 diabetes: epidemiological analysis of the ACCORD-MIND MRI trial.The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study.Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose.Glycemia and cognitive function in metabolic syndrome and coronary heart disease.Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics E3 ubiquitin ligase Siah-1 downregulates synaptophysin expression under high glucose and hypoxia.Vascular factors and multiple measures of early brain health: CARDIA brain MRI study.

P2860

Q24632533-1CB2D760-2EF4-447F-BF5E-B740A6C938D1 Q26740260-B47C9C52-5400-4151-81C6-E04303671CB9 Q26749493-EAE9193F-0F99-4D22-A7AC-ED69DA1E4EEC Q26773657-0A78DFA4-073A-45D5-B961-30295BBE71FF Q26783276-24D982E0-4A16-4CAB-99A3-A033D00E1C55 Q26822993-90BDF0C6-2745-4859-8474-CD752ACC4A51 Q28079459-FB670608-D8F1-47AA-912E-3458A0D5D3B0 Q29620309-666D39AD-6765-4FC2-9675-96E024460D6C Q30528669-992101AD-3DE5-496B-AEBB-DD1B9080F730 Q30772562-72928826-37C3-4978-9B3A-46F4C0BB23A3 Q30811136-4523D36C-A8E9-46E9-88D2-F7DCE8869069 Q30978064-F9C16A12-14CE-4EC6-8EBF-34B1B7742EA1 Q31119662-E9AE1BE5-CA47-4CBE-97B7-94F166F952D3 Q33561550-4AED4B78-D402-41BE-B8C4-D0C883B2B364 Q33603286-977B72DE-C4B4-4E34-BE2D-D52A565D1CC1 Q33688987-D639C6CA-FDD1-4837-B5B5-AC3B39BA11FC Q33699538-4C3EBCF6-5031-4233-A899-A2CF4D1EBF9B Q33737907-F442BAC9-8538-4E5F-A631-F2E09FF0034F Q33780337-5AADF103-9D97-483F-B4D7-9A628781B6CA Q33857774-51439292-C699-4AB1-BA4D-DA0F2A6B2FFB Q33859442-859F9F22-4B35-479E-8D31-B488928D3BF0 Q33892591-CCF2E9BE-B267-40D3-8A6C-7CF9684A4CE9 Q33915696-6AD66734-124B-40FC-B512-847D190DBA7E Q34044849-D6C6F2ED-F503-4070-A45D-D0BD558E015B Q34143299-D20CCCC3-67C9-43EC-A0D1-7361A82FB2F3 Q34263961-474EC42F-3ABE-4660-905A-DBA7925A9B26 Q34308751-4BD57A4B-EAC8-48F7-8205-6F4BCBE4CC57 Q34349059-B75282EC-D358-4196-AE7A-9360878E7B3B Q34443537-730ED37F-CA24-4927-AB5A-EFDEEE4943A2 Q34482535-D550B329-E745-4609-95F8-0DCB76C87E23 Q34515561-80482988-0819-4C56-8365-738630EA64F1 Q34545326-0D367A35-B502-4B26-B15E-B2F7376507E5 Q34545383-F388B175-CA72-48C1-B7CE-54149CA89895 Q34760782-B0015DEC-DBB9-403B-9BCA-A41DCA9A5260 Q34762299-19C6DB9D-8418-4C9C-9CD9-00D1AB7F6039 Q35013166-7AAE431A-12BF-4D79-9F62-993FA9572196 Q35040454-088B04BA-1A84-4864-AC70-A84A0C1BEB70 Q35089500-DAD22018-60AC-4A6F-8CB5-65DE556AA93C Q35137783-AA08059E-AFDD-4138-8962-1961778385BF Q35220201-A8B0507D-B95C-4B05-A9B7-B8857BA64211

P2860

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.

http://www.wikidata.org/entity/Q35905639

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Effects of intensive glucose l ...... andomised open-label substudy.

@ast

Effects of intensive glucose l ...... andomised open-label substudy.

@en

type

label

Effects of intensive glucose l ...... andomised open-label substudy.

@ast

Effects of intensive glucose l ...... andomised open-label substudy.

@en

prefLabel

Effects of intensive glucose l ...... andomised open-label substudy.

@ast

Effects of intensive glucose l ...... andomised open-label substudy.

@en

P1433

Q35905639-56560959-CB41-44DA-BA49-598BF3DBB256

P1476

Q35905639-0A6710BC-C72A-449D-9080-38614AA47152

P2093

Q35905639-0848B3B7-374C-45EA-A71B-E99CE3CF58A9

Q35905639-0E78C074-01CF-4D62-9CB6-36AE5C32B08C

Q35905639-18F2983A-9D62-4F9C-8AE9-01995DABBBE5

Q35905639-1F27631E-B6C2-4F4D-A3D0-AF176814B5AC

Q35905639-27815F64-145D-434A-B228-E14C19637D22

Q35905639-403A75F7-382E-4341-920D-13ADDF9B5A42

Q35905639-41E69CDA-F6B8-49A6-A7ED-4E7CCDD6A380

Q35905639-4283AABD-25C4-48EE-854C-479225C45EB4

Q35905639-43BEB98D-B5F3-4826-ABB9-52D1129BA80D

Q35905639-62B49B3B-4BFA-4315-BAF0-33A7E2C226CF

P2860

Q35905639-0B2F87F7-1B1F-4EAB-8D7A-6568527D0F7B

Q35905639-0D538C26-A9C1-4BC5-A58A-2C9965888A3B

Q35905639-1351E00C-85BD-408D-9D3E-B40C27080F2D

Q35905639-1D059F03-6518-40B8-BDBF-FDE1AF191829

Q35905639-22348DE4-ABBC-4E50-8E64-DDDAE7B027AE

Q35905639-239ABFB0-5395-4EE9-A944-8939197A6936

Q35905639-23E58EFF-4D77-4031-9CE7-40D59A56D04E

Q35905639-2A283ED7-0568-42B9-AEE1-45F6962E5B89

Q35905639-2BB69DAB-9F9D-4F0B-98DD-D27BE302DC2B

Q35905639-2DD0170A-BEAF-45A8-8530-EC5C797E7F2C

P304

Q35905639-E0206710-5CD5-4A7F-A1C9-033ED5E1B725

P31

Q35905639-2B794DB8-EE14-4D91-BA45-BC6CBDBEE381

P356

Q35905639-A71298BF-EDD5-4291-BC52-B00160474DEE

P433

Q35905639-EC47CFD8-F325-4343-BFAC-5256C784B389

P478

Q35905639-D4A2084F-37AA-4093-81F5-F732E896B1EC

P50

Q35905639-474E821C-1F94-425F-B8BE-832330E160CE

Q35905639-8DA82059-7ABE-4145-AE49-F1D6C667307F

Q35905639-A003E6AD-E8F6-4DB1-A330-F3D3E375D62A

Q35905639-CE663E41-7C56-4E80-ACF3-73E6D9E7E195

Q35905639-EB063C3C-59AE-4A1F-A162-2AD83D1ADD51

P577

Q35905639-427D0DDB-3C9D-471A-956E-569B37324E51

P698

Q35905639-05597DFB-2026-46CE-A7A8-DA0A614E8917

P921

Q35905639-6021D15C-2976-4C6B-BBA0-4118A016759A

P932

Q35905639-03BFA258-3A57-4858-A5F0-346719AA5046

P356

S1474-4422(11)70188-0

P1433

Lancet Neurology

P1476

Effects of intensive glucose l ...... andomised open-label substudy.

@en

P2093

ACCORD MIND investigators

http://www.w3.org/2001/XMLSchema#string

Anne M Murray

http://www.w3.org/2001/XMLSchema#string

Charles Truwit

http://www.w3.org/2001/XMLSchema#string

Edward W Lipkin

http://www.w3.org/2001/XMLSchema#string

James Lovato

http://www.w3.org/2001/XMLSchema#string

Jeff D Williamson

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Sunshine

http://www.w3.org/2001/XMLSchema#string

Jingzhong Ding

http://www.w3.org/2001/XMLSchema#string

Karen L Margolis

http://www.w3.org/2001/XMLSchema#string

Karen R Horowitz

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical use of structural MRI in Alzheimer disease

Aging and measures of processing speed

Effects of intensive glucose lowering in type 2 diabetes

Brain imaging in patients with diabetes: a systematic review.

The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis

Pre-MRI procedure screening: recommendations and safety considerations for biomedical implants and devices.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

The brain in diabetes: molecular changes in neurons and their implications for end-organ damage.

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies.

Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.

P304

969-977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1474-4422(11)70188-0

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Christos Davatzikos

Joseph A. Maldjian

Hertzel C. Gerstein

Lenore J Launer

P577

2011-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21958949

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3333485

http://www.w3.org/2001/XMLSchema#string